
13% Revenue, 55% Profit Collapse: The Provision Gap HCG Won't Repeat
oncology · margin regulation · price caps
BSE: 539787
P/L Snapshot
Q2 FY27 · standalone
Shareholding
Pattern breakdown
P/L Trends
(in crores)

oncology · margin regulation · price caps

revenue growth slowing · PAT decline masked by adjustments · price cap risk

HCG · oncology · ARPP stagnation
Corporate Events
Board Meeting
The meeting of the Board of Directors is scheduled to consid…
BSE Filing ↗Board Meeting
The Twenty Eighth (28th) Annual General Meeting ("AGM") of t…
BSE Filing ↗Board Meeting
The Nomination and Remuneration Committee of the Board of Di…
BSE Filing ↗Board Meeting
The meeting of the Board of Directors is scheduled to consid…
BSE Filing ↗Board Meeting
To consider and decide various matters related to the Rights…
BSE Filing ↗Board Meeting
Consider, approve and take on record the Unaudited Financial…
BSE Filing ↗Board Meeting
Consider, approve and take on record the Unaudited Financial…
BSE Filing ↗Board Meeting
Consider, approve and take on record the Unaudited Financial…
BSE Filing ↗Board Meeting
consider and approve the unaudited financial results of the …
BSE Filing ↗